Conference Call and Webcast
Tuesday, March 8th, 2011 at 4:30pm ET
Speakers:
Med BioGene Inc.
Erinn B. Broshko
Chief Executive Officer
About Med BioGene:
MBI, a life-science company based in Vancouver, British Columbia, is focused on the development and commercialization of genomic-based personalized clinical laboratory diagnostic tests. MBI is committed to advancing personalized medicine by commercializing tests that provide clinically relevant information to improve patient treatment and reduce health care costs. MBI's common shares are traded on the TSX Venture Exchange. For more information, please visit www.medbiogene.com.
The following information is required to view this webcast.
Please complete all of the information to continue.